BridgeBio Pharma, Inc.
BBIO
$32.89
$0.702.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 681.10M | 266.32M | 447.77M | 519.69M | 434.88M |
| Total Receivables | 4.72M | 478.00K | 660.00K | 235.49M | 1.75M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 31.04M | 28.87M | 28.40M | 28.11M | 24.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.83M | 148.91M | 139.41M | 131.00K | 16.65M |
| Total Current Assets | 720.69M | 444.58M | 616.24M | 783.42M | 477.59M |
|
|
|||||
| Total Current Assets | 720.69M | 444.58M | 616.24M | 783.42M | 477.59M |
| Net Property, Plant & Equipment | 12.78M | 15.14M | 17.11M | 19.47M | 19.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 23.93M | 24.53M | 25.12M | 25.72M | 26.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.20M | 20.29M | 18.90M | 20.72M | 21.03M |
| Total Assets | 919.34M | 664.98M | 794.38M | 849.33M | 546.38M |
|
|
|||||
| Total Accounts Payable | 9.62M | 13.36M | 18.13M | 4.73M | 10.66M |
| Total Accrued Expenses | 124.08M | 104.70M | 90.14M | 109.48M | 116.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.51M | 4.60M | 4.62M | 4.54M | 4.13M |
| Total Finance Division Other Current Liabilities | 16.20M | 16.56M | 21.48M | 22.73M | 12.10M |
| Total Other Current Liabilities | 16.20M | 16.56M | 21.48M | 22.73M | 12.10M |
| Total Current Liabilities | 154.40M | 139.22M | 134.36M | 141.48M | 143.84M |
|
|
|||||
| Total Current Liabilities | 154.40M | 139.22M | 134.36M | 141.48M | 143.84M |
| Long-Term Debt | 1.72B | 1.72B | 1.72B | 1.72B | 1.73B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.70M | 5.83M | 7.06M | 8.30M | 8.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 496.47M | 19.00M | 17.45M | 20.49M | 9.36M |
| Total Liabilities | 2.38B | 1.88B | 1.88B | 1.89B | 1.89B |
|
|
|||||
| Common Stock & APIC | 1.90B | 1.88B | 1.85B | 1.82B | 1.48B |
| Retained Earnings | -3.10B | -2.83B | -2.67B | -2.60B | -2.56B |
| Treasury Stock & Other | -274.99M | -275.00M | -275.00M | -275.00M | -274.97M |
| Total Common Equity | -1.47B | -1.23B | -1.09B | -1.05B | -1.35B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.47B | -1.23B | -1.09B | -1.05B | -1.35B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 10.29M | 11.53M | 10.83M | 12.67M | 11.72M |
| Total Equity | -1.46B | -1.22B | -1.08B | -1.04B | -1.34B |
|
|
|||||
